2779. Early Administration of Ceftazidime-Avibactam for Carbapenem-Resistant Enterobacterales Is Associated with Improved Clinical Success

BACKGROUND: Carbapenem-resistant Enterobacterales (CRE) are a significant public health threat. Ceftazidime-avibactam (CZA) retains activity against most carbapenemase-producing CRE and demonstrates favorable health outcomes compared to historically best available therapy. While early initiation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyne, Ashlan J Kunz, Lucas, Kristen, Shald, Elizabeth, Cabanilla, M Gabriela, Yost, Christine, VanDorf, Sydney, Slaton, Cara, Kufel, Wesley D, Truong, James, Andrade, Justin A, Cerenzio, John, Biagi, Mark, Todd, Michaela, White, Bryan, Sassine, Joseph, Hayes, Jillian E, Witucki, Paige, Orzol, Carolina, Eshaya, Mirna, Bleick, Callan, Caniff, Kaylee E, Veve, Michael P, Rybak, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677411/
http://dx.doi.org/10.1093/ofid/ofad500.2390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677411/
http://dx.doi.org/10.1093/ofid/ofad500.2390

Ejemplares similares